Assessment of Pouch Emptying With MRI After Roux-en-Y Gastric Bypass
NCT ID: NCT06298162
Last Updated: 2024-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2019-07-25
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Extended Pouch Roux-en-Y Gastric Bypass Study
NCT02218957
Fat Absorption and Metabolism After Roux-en-Y Gastric Bypass
NCT04859816
Photographic Food Recognition and Meal Size Estimation Before and After Roux-en-Y Gastric Bypass
NCT04600596
Changes in Gut Hormones, Body Composition and Energy Expenditure After Roux-en-Y
NCT02048501
Endoscopic Stomach and Pouch Reduction in Patients With Weight Regain Following Roux-En-Y Bypass Surgery
NCT00411489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RYGB, successful weight loss (TWL >35%)
TWL = total weight loss
2 years after RYGB, no intervention. MRI measurement. Observational.
no intervention. MRI measurement. Observation.
RYGB, unsuccessful weight loss (TWL <25%)
2 years after RYGB, no intervention. MRI measurement. Observational.
no intervention. MRI measurement. Observation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2 years after RYGB, no intervention. MRI measurement. Observational.
no intervention. MRI measurement. Observation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must be able to adhere to the study visit schedule and protocol requirements
* Patients must be able to give informed consent (IC) prior to any study procedures
* Patients who had a follow-up period up until two years after LRYGB and have successful or unsuccessful weight loss.
* Willing to be informed about incidental findings of pathology and approving of reporting this to their general physician
Exclusion Criteria
* Menopausal
* Gastrointestinal problems, gastric or intestinal diseases
* Drug or alcohol addiction
* Inability to stop smoking during the overnight fasting period
* Pregnant or lactating
* Having an intolerance or allergy for one of the components of the test product
* Inability to stop medications that affect gastrointestinal emptying like antisecretory drugs, narcotics and prokinetic agents
* Inability to stop medication that affects the motility of the upper gastrointestinal tract (anti-cholinergic drugs, prokinetics, theophylline, calcium blocking agents, opioids)
* Having a contra-indication to MRI scanning (including, but not limited to):
* Pacemakers and defibrillators
* Intraorbital or intraocular metallic fragments
* Ferromagnetic implants
20 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rijnstate Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yonta Burgh
Arnhem, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-1279
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.